Binx iO Molecular Point-of-Care Platform Instrument

SKU

BNX-3.001.001

$13,000.00

(1 Binx io Instrument with starter Kit)

The binx io is a CLIA-waived, point-of-care PCR test for CT/NG (males & females) that delivers confirmed results in 30 minutes. This enables true test-and-treat in a single visit, improving antibiotic stewardship and quality scores.

The first CLIA-Waived molecular point-of-care solution for the rapid detection of chlamydia & gonorrhea!

With CLIA Waiver, the binx io expands access to laboratory-based quality testing in near-patient settings holding CLIA-certificates of waiver such as primary care offices, urgent cares, community clinics, emergency rooms, and retail pharmacies!

Ask about free analyzer with signed commitment contract of 25 tests per month!

Contact [email protected] for details!

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Details

First ever FDA 510(k), CLIA-Waived CT/NG molecular test for males and females, enabling same-visit diagnosis and treatment
Gives results comparable to a laboratory-based test for chlamydia and gonorrhea in about 30 minutes rather than days or weeks
Easy to use desktop-sized instrument that can be operated by non-laboratory trained personnel in CLIA-Waived settings
Potential financial benefits for your healthcare practice

Product Attachments

We’re Temporarily Offline

We’ll be back online in few hours

Binx iO Molecular Point-of-Care Platform Instrument